LiPKChowKMChoY, et al.ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int2022; 42(2): 110–153.
3.
LamMFTangBSTseKC, et al.Ampicillin-sulbactam and amikacin used as second-line antibiotics for patients with culture-negative peritonitis. Perit Dial Int2008; 28(5): 540–542.
4.
LingCWSudKVanC, et al.Practice variations in antibiotic administration for the management of peritonitis in patients on automated peritoneal dialysis in Australia and New Zealand. Perit Dial Int2022; 42(6): 647–651.
5.
LingCWSudKVanC, et al.Pharmacokinetics of culture-directed antibiotics for the treatment of peritonitis in automated peritoneal dialysis: a systematic narrative review. Perit Dial Int2021; 41(3): 261–272.
6.
Falbo Dos ReisPBarrettiPMarinhoL, et al.Pharmacokinetics of intraperitoneal vancomycin and amikacin in automated peritoneal dialysis patients with peritonitis. Front Pharmacol2021; 12: 658014.
7.
MulhernJGBradenGLO’SheaMH, et al.Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients. Am J Kidney Dis1995; 25(4): 611–615.
8.
BlundenMZeitlinDAshmanN, et al.Single UK Centre experience on the treatment of PD peritonitis – antibiotic levels and outcomes. Nephrol Dial Transplant2007; 22(6): 1714–1719.
9.
StevensonSTangWChoY, et al.The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis. Perit Dial Int2015; 35(2): 222–228.
10.
DahlanRLavoieSBiyaniM, et al.A high serum vancomycin level is associated with lower relapse rates in coagulase-negative staphylococcal peritonitis. Perit Dial Int2014; 34(2): 232–235.
11.
MaYGengYJinL, et al.Serum vancomycin levels predict the short-term adverse outcomes of peritoneal dialysis-associated peritonitis. Perit Dial Int2023; 43(1): 37–44.
12.
LamELienYTKKraftWK, et al.Vancomycin in peritoneal dialysis: clinical pharmacology considerations in therapy. Perit Dial Int2020; 40(4): 384–393.
13.
HoEGleesonSRobertsS, et al.Vancomycin use for haemodialysis patients – development of a new dosing protocol. Nephrology (Carlton)2023; 28(4): 227–233.
14.
DeaconECanneyMMcCormickB, et al.Predictors of serum vancomycin levels in peritoneal dialysis-associated peritonitis. Perit Dial Int2023; 43(1): 45–52.
